Vaxigrip Tetra Inj 1’s
KSh 1,915.00
Vaxigrip Tetra Inj 1’s is a quadrivalent influenza vaccine (split virion, inactivated) that is used to prevent influenza disease. It contains four different strains of inactivated influenza virus for the 2024 Southern Hemisphere in each 0.5 mL dose. The vaccine is presented in a pre-filled syringe as a colorless opalescent liquid, devoid of any visible particulate matter.
Vaccine
Why You'll Love It
Vaxigrip Tetra is approved for the active immunization of adults, pregnant women, and children aged 6 months and above against influenza caused by specific virus subtypes. Annual vaccination at the start of flu season is advised.
Suggested Use
Caution
What's In It
Warning
In the event that you or your child has a history of severe allergic reactions to the active substances, any of the other ingredients of this vaccine, or any component that may be present in very small amounts such as eggs (ovalbumin), neomycin, formaldehyde, or octoxinol-94, it is essential to refrain from administering Vaxigrip Tetra. It is important to understand that, like other vaccines, Vaxigrip Tetra may not offer complete protection to all individuals who receive it. It is crucial to be aware of the potential serious side effects associated with this vaccine. These can include severe allergic reactions, pain along the nerve route, fits, neurological disorders that may lead to a stiff neck, confusion, numbness, limb pain and weakness, loss of balance, loss of reflexes, paralysis of part or all of the body, and inflammation of blood vessels that may result in skin rashes and, in extremely rare cases, temporary kidney problems. Common side effects may include pain, tenderness, redness, swelling, bruising, and hardness at the injection site, as well as headache, muscle aches, general discomfort, fever, and shivering.